Madrigal Pharmaceuticals (MDGL) Other Working Capital Changes (2010 - 2026)

Madrigal Pharmaceuticals (MDGL) has 17 years of Other Working Capital Changes data on file, last reported at $40.6 million in Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 329.88% year-over-year to $40.6 million in Q1 2026; TTM through Mar 2026 was $65.2 million, a 608.28% increase from a year earlier, with the FY2025 full-year figure at $34.0 million, up 219.84% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at $40.6 million, up from -$1.5 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for MDGL reached as high as $40.6 million in Q1 2026 and fell as low as -$9.3 million in Q3 2025.
• Historically, Other Working Capital Changes has averaged $5.1 million across 5 years, with a median of $928000.0 in 2024.
• On a YoY basis, Other Working Capital Changes climbed as much as 10096.61% in 2024 and fell as far as 22209.38% in 2024.
• Year by year, Other Working Capital Changes stood at -$1.3 million in 2022, then jumped by 102.42% to $32000.0 in 2023, then slumped by 22209.38% to -$7.1 million in 2024, then jumped by 78.45% to -$1.5 million in 2025, then surged by 2765.51% to $40.6 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $40.6 million in Q1 2026, -$1.5 million in Q4 2025, and -$9.3 million in Q3 2025.